Who are VERSATOPE THERAPEUTICS, INC.'s investors?

VERSATOPE THERAPEUTICS, INC.'s investors include MassVentures.

When was VERSATOPE THERAPEUTICS, INC. founded?

VERSATOPE THERAPEUTICS, INC. was founded in 2018.

Where is VERSATOPE THERAPEUTICS, INC. headquartered?

VERSATOPE THERAPEUTICS, INC. is headquartered in LOWELL, Massachusetts, United States.

What industry is VERSATOPE THERAPEUTICS, INC. in?

VERSATOPE THERAPEUTICS, INC. operates in Biotech, Healthcare.

How many employees does VERSATOPE THERAPEUTICS, INC. have?

VERSATOPE THERAPEUTICS, INC. has 11-50 employees.

VERSATOPE THERAPEUTICS, INC.

Immuno-Therapeutics Through a Customized Biotechnology Platform

LOWELL, United States · Founded 2018

Biotech

Healthcare

Headquarters: LOWELL, Massachusetts
Employees: 11–50
Founded: 2018
Business Model: B2G

Website: versatope.com
Last Round: GrantJan 2024
Rounds: 1

About

Versatope Therapeutics is a clinical-stage infectious disease company that uses synthetic biology to engineer recombinant nanovesicles derived from microbial membranes as a platform for targeted vaccine and immunotherapeutic delivery. The company's lead program, VT-105, is a universal influenza A vaccine candidate that has received IND allowance. Versatope's platform is also being applied to malaria vaccine development.

Summary

VERSATOPE THERAPEUTICS, INC. is a Biotech company based in LOWELL, United States, founded in 2018. Its most recent funding was a Grant round in Jan 2024. Investors include MassVentures.

LinkedIn X (Twitter)